Company: BOLT
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641281-25-000007
Chunk: 0

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
BOLT BIOTHERAPEUTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS 

(Unaudited, in thousands, except share and per share amounts) 

     June 30,

     December 31,

     2025

     2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     9,601

     $
     7,205

     Short-term investments

     25,168

     40,118

     Restricted cash

     784

     784

     Prepaid expenses and other current assets

     2,783

     2,707

     Total current assets

     38,336

     50,814

     Property and equipment, net

     1,718

     3,139

     Operating lease right-of-use assets

     20,517

     21,756

     Restricted cash, non-current

     981

     981

     Long-term investments

     13,725

     22,880

     Other assets

     222

     62

     Total assets
      
     $
     75,499

     $
     99,632

     Liabilities and stockholders' equity

     Current liabilities:

     Accounts payable
      
     $
     1,852

     $
     1,507

     Accrued expenses and other current liabilities

     5,387

     9,083

     Deferred revenue

     2,512

     3,015

     Operating lease liabilities

     2,559

     2,251

     Total current liabilities

     12,310

     15,856

     Operating lease liabilities, net of current portion

     21,624

     22,958

     Deferred revenue, non-current

     2,590

     3,620

     Other long-term liabilities

     133

     —

     Total liabilities

     36,657

     42,434

     Commitments and contingencies (Note 6)

     Stockholders' equity:

     Common stock, $0.00001 par value; 200,000,000 shares authorized at June 30, 2025 and December 31, 2024; 1,919,441 and 1,916,943 shares issued and outstanding at June